Epigenomics AG
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The co…
Medical - Diagnostics & Research
DE, Berlin [HQ]
EPGNF/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million EUR. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 4.00 | 1.00 | 1.00 | 1.00 | - - | 6.00 | - - | - - | |
|
EPS
|
-9.14 | -37.02 | -46.06 | -39.31 | -17.68 | -18.51 | -14.96 | -15.69 | -12.59 | -14.74 | -71.65 | -39.67 | -4.33 | -14.78 | -5.23 | |
| Diluted in mil. | -9.14 | -37.02 | -46.06 | -39.31 | -17.68 | -18.51 | -14.96 | -15.69 | -12.59 | -14.74 | -71.65 | -39.67 | -4.33 | -14.78 | -5.23 | |
|
Profit
|
1.00 | 1.00 | 1.00 | - - | 1.00 | - - | - - | 2.00 | 1.00 | 1.00 | - - | - - | 6.00 | - - | - - | |
| Gross Margin | 34.32 | 73.48 | 75.16 | 71.90 | 69.33 | 51.49 | 43.56 | 61.10 | 86.80 | 71.30 | 77.51 | 82.78 | 97.81 | 75.26 | 83.22 | |
| Pre Tax | -10.00 | -11.00 | -15.00 | -12.00 | -7.00 | -8.00 | -9.00 | -12.00 | -10.00 | -13.00 | -14.00 | -11.00 | -2.00 | -12.00 | -4.00 | |
| Profit Margin | -235.23 | -639.96 | -1,065.97 | -1,159.10 | -458.25 | -589.32 | -444.24 | -292.69 | -560.57 | -876.06 | -1,294.76 | -1,385.15 | -38.85 | -2,495.05 | -1,315.79 | |
| ETR | -2.02 | -0.35 | -1.68 | -1.28 | -1.84 | 0.30 | 2.85 | 9.23 | 2.05 | 5.50 | -16.85 | -0.20 | -0.75 | 0.64 | - - | |
| Net | -10.00 | -11.00 | -15.00 | -12.00 | -7.00 | -8.00 | -8.00 | -11.00 | -10.00 | -12.00 | -17.00 | -11.00 | -2.00 | -12.00 | -4.00 | |
| Profit Margin | -239.98 | -642.19 | -1,083.86 | -1,173.92 | -466.69 | -587.52 | -431.56 | -265.67 | -549.09 | -827.92 | -1,512.89 | -1,387.89 | -39.14 | -2,479.18 | -1,315.79 | |
| EBITDA | -9.00 | -10.00 | -10.00 | -11.00 | -6.00 | -7.00 | -8.00 | -11.00 | -10.00 | -12.00 | -13.00 | -11.00 | -1.00 | -11.00 | -3.00 | |
| EBITDA Margin | -216.83 | -576.05 | -761.24 | -1,069.01 | -403.97 | -501.19 | -411.77 | -284.15 | -541.36 | -820.03 | -1,243.47 | -1,315.08 | -31.15 | -2,313.81 | -1,065.23 | |
| Operating Income | -10.00 | -11.00 | -15.00 | -12.00 | -7.00 | -8.00 | -9.00 | -12.00 | -10.00 | -12.00 | -14.00 | -11.00 | -2.00 | -12.00 | -4.00 | |
| Operating Margin | -239.86 | -640.68 | -1,060.89 | -1,166.79 | -458.94 | -556.27 | -444.96 | -293.07 | -551.98 | -841.16 | -1,304.27 | -1,380.88 | -37.95 | -2,484.74 | -1,231.19 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Loss | -14.00 | -13.00 | -16.00 | -13.00 | -8.00 | -9.00 | -11.00 | -16.00 | -11.00 | -14.00 | -16.00 | -10.00 | -10.00 | -13.00 | -4.00 | |
| Cost of Revenue | -2.00 | - - | - - | - - | - - | - - | -1.00 | -1.00 | - - | - - | - - | - - | - - | - - | - - | |
|
Operating Expenses
|
-11.00 | -12.00 | -16.00 | -12.00 | -8.00 | -9.00 | -10.00 | -15.00 | -11.00 | -14.00 | -15.00 | -10.00 | -10.00 | -13.00 | -4.00 | |
| R&D | -7.00 | -7.00 | -4.00 | -8.00 | -4.00 | -4.00 | -5.00 | -5.00 | -4.00 | -6.00 | -7.00 | -3.00 | -3.00 | -6.00 | - - | |
| G&A | -3.00 | -5.00 | -5.00 | -5.00 | -4.00 | -4.00 | -5.00 | -10.00 | - - | - - | - - | - - | - - | - - | - - | |
| SG&A | -4.00 | -5.00 | -5.00 | -5.00 | -4.00 | -4.00 | -5.00 | -10.00 | -4.00 | -4.00 | -4.00 | -3.00 | -4.00 | -4.00 | -4.00 | |
| S&M | -1.00 | - - | - - | - - | -4.00 | - - | - - | -5.00 | -4.00 | -4.00 | -4.00 | -3.00 | -4.00 | -4.00 | - - | |
| Depreciation and Amortization | - - | -1.00 | -4.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Interest Expenses | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Expenses | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
WA Shares Outstanding
|
1.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Diluted | 1.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |